share_log

Pfizer | 3: Initial statement of beneficial ownership of securities-Director Buckley Mortimer J

Pfizer | 3: Initial statement of beneficial ownership of securities-Director Buckley Mortimer J

辉瑞 | 3:首次持股声明-董事 Buckley Mortimer J
美股SEC公告 ·  10/16 05:35

Moomoo AI 已提取核心信息

Pfizer Inc. (PFE) has filed an SEC Form 3, indicating an initial statement of beneficial ownership of securities by Mortimer J. Buckley, a director and 10% owner of the company. The form, which was filed on October 15, 2024, pertains to an event that occurred on October 10, 2024. According to the filing, Buckley does not beneficially own any Pfizer securities at the time of the report. The form was submitted by Susan E. Grant, under power of attorney for Buckley. This filing is a routine disclosure required by the Securities Exchange Act of 1934 and the Investment Company Act of 1940 for directors, officers, and principal shareholders.
Pfizer Inc. (PFE) has filed an SEC Form 3, indicating an initial statement of beneficial ownership of securities by Mortimer J. Buckley, a director and 10% owner of the company. The form, which was filed on October 15, 2024, pertains to an event that occurred on October 10, 2024. According to the filing, Buckley does not beneficially own any Pfizer securities at the time of the report. The form was submitted by Susan E. Grant, under power of attorney for Buckley. This filing is a routine disclosure required by the Securities Exchange Act of 1934 and the Investment Company Act of 1940 for directors, officers, and principal shareholders.
辉瑞公司(PFE)已提交了一份SEC表格3,表明莫蒂默·J·巴克利(Mortimer J. Buckley)是该公司的一名董事兼持有10%股权的初始有益所有权报告人。该表格于2024年10月15日提交,涉及2024年10月10日发生的事件。根据备案,巴克利在报告时并不拥有任何辉瑞证券。该表格由苏珊·E·格兰特(Susan E. Grant)代表巴克利提交。这份申报是根据1934年证券交易法和1940年投资公司法对董事、高管和主要股东所要求的例行披露。
辉瑞公司(PFE)已提交了一份SEC表格3,表明莫蒂默·J·巴克利(Mortimer J. Buckley)是该公司的一名董事兼持有10%股权的初始有益所有权报告人。该表格于2024年10月15日提交,涉及2024年10月10日发生的事件。根据备案,巴克利在报告时并不拥有任何辉瑞证券。该表格由苏珊·E·格兰特(Susan E. Grant)代表巴克利提交。这份申报是根据1934年证券交易法和1940年投资公司法对董事、高管和主要股东所要求的例行披露。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息